Allogeneic Blood or Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis for Myelodysplastic Syndrome/Myeloproliferative Neoplasm-Overlap Syndromes (MDS/MPN)

被引：0
|
作者：
Karantanos, Theodoros
Tsai, Hua-Ling
Gondek, Lukasz P.
Levis, Mark
Showel, Margaret M.
DeZern, Amy E.
Gojo, Ivana
Varadhan, Ravi
Jones, Richard J.
Jain, Tania
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Graft-Versus-Host Disease (GvHD) Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation (haplo-PBSCT) Using Abatacept in Combination with Post-Transplant Cyclophosphamide (PTCy)
    Kaur, Sukhdeep
    Gelman, Simon
    Rowley, Scott
    Baker, Eliana
    Baker, Melissa
    Suh, Hyung C.
    Cho, Christina
    Donato, Michele L.
    BLOOD, 2023, 142
  • [42] LYMPHOCYTE-T DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - OCCURRENCE OF GRAFT VERSUS HOST-DISEASE (GVHD) AND RECOVERY OF LYMPHOCYTE FUNCTION POST-BMT
    TRIGG, ME
    BOZDECH, MJ
    BILLING, R
    SONDEL, PM
    FINLAY, JL
    HONG, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 197 - 197
  • [43] Risk Factors for Graft-Versus-Host Disease (GVHD) in Haploidentical Hematopoietic Cell Transplantation (HCT) Using Post-Transplant Cyclophosphamide (PTCy)
    Rashidi, Armin
    Hamilton, Betty K.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Alousi, Amin M.
    Jagasia, Madan
    Pidala, Joseph A.
    Arora, Mukta
    Im, Annie P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [44] Extended Follow-up of Myeloablative, HLA-Matched Allogeneic BMT with High-Dose, Post-Transplantation Cyclophosphamide (PTCy) As Sole GVHD Prophylaxis: Favorable Outcomes Despite Low Incidence of Chronic GVHD
    Kanakry, Christopher G.
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Smith, B. Douglas
    Gojo, Ivana
    Kasamon, Yvette L.
    Kanakry, Jennifer A.
    Zahurak, Marianna
    Fuchs, Ephraim J.
    Jones, Richard J.
    Luznik, Leo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S37 - S37
  • [45] Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
    Saberian, Chantal
    Abdel-Wahab, Noha
    Abudayyeh, Ala
    Rafei, Hind
    Joseph, Jacinth
    Rondon, Gabriela
    Whited, Laura
    Gruschkus, Stephen
    Fa'ak, Faisal
    Daher, May
    Knape, Cristina
    Safa, Houssein
    Shoukier, Mahran
    Suarez-Almazor, Maria E.
    Marcotulli, Megan
    Ludford, Kaysia
    Gulbis, Alison M.
    Konopleva, Marina
    Ohanian, Maro
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Oran, Betul
    Popat, Uday R.
    Mehta, Rotesh
    Alousi, Amin M.
    Daver, Naval
    Champlin, Richard
    Diab, Adi
    Al-Atrash, Gheath
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [46] Myeloid-derived suppressor cell (MDSC) recovery after allogeneic hematopoietic cell transplantation (ALLOHCT) using post-transplant cyclophosphamide (PTCY) as graft-versus-host disease (GVHD) prophylaxis in children
    Oshrine, Benjamin
    Verdugo, Patrick
    Innamarato, Pasquale
    Pilon-Thomas, Shari
    BONE MARROW TRANSPLANTATION, 2019, 54 : 485 - 486
  • [47] HLA-Matched Sibling Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis: A Single Center Experience
    Fathy, Gamal M.
    Mahmoud, Hossam K.
    El-Haddad, Alaa
    Fahmy, Omar
    Abdelfattah, Raafat
    Abdel-Mooti, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S262 - S262
  • [48] PHASE I/II STUDY OF CYCLOPHOSPHAMIDE AND BENDAMUSTINE AS POST-TRANSPLANTATION GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN REFRACTORY MYELOID NEOPLASMS
    Moiseev, Ivan
    Epifanovskaya, Olga
    Afanasyeva, Ksenia
    Beynarovich, Anastasia
    Zhogolev, Dmitrii
    Kanunnikov, Mikhail
    Rogacheva, Yulia
    Rudakova, Tatyana
    Volkov, Nikita
    Khudaiberdiev, Zhamshidbek
    Meliboev, Azamjon
    Vlasova, Yulia
    Morozova, Elena
    Bondarenko, Sergei
    Kulagin, Alexander
    BONE MARROW TRANSPLANTATION, 2024, 59 : 157 - 158
  • [49] Treatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes
    Herzog, Shannon
    Shanley, Ryan
    Holtan, Shernan G.
    MacMillan, Margaret L.
    Weisdorf, Daniel J.
    El Jurdi, Najla
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (07): : 688.e1 - 688.e9
  • [50] Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Anti-Thymocyte Globulin As Graft Versus Host Disease Prophylaxis
    Gay, Queralt Salas
    Law, Arjun
    Lam, Wilson
    Al-Shaibani, Zeyad
    Michelis, Fotios V.
    Thyagu, Santhosh
    Kim, Dennis Dong Hwan
    Lipton, Jeff H.
    Kumar, Rajat
    Viswabandya, Auro
    BLOOD, 2018, 132
12345